Rhythm Pharmaceuticals Inc (NAS:RYTM)
$ 55.59 -0.95 (-1.68%) Market Cap: 3.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 308.96 GF Score: 58/100

Rhythm Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 17, 2023 / 07:00PM GMT
Release Date Price: $20.45 (+5.41%)
Joey Stringer
Needham & Company - Analyst

Good afternoon, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Rhythm Pharmaceuticals.

Joining us today from Rhythm is President and CEO, David Meeker. For those of you joining on the webcast, if you want to ask a question, you can do so at any time. You can submit a question using the chat box feature at the bottom of your screen. So with that, we'll go ahead and get started.

Questions & Answers

Joey Stringer
Needham & Company - Analyst

David, thank you so much for joining us today.

David Meeker
Rhythm Pharmaceuticals, Inc. - President & CEO

Thank you, Joey. Pleasure to be here.

Joey Stringer
Needham & Company - Analyst

Well, we'll start off with the IMCIVREE launch. We'll get right into it. How would you [handicap

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot